TECLens Overview

  • Founded
  • 2013
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $200K
Latest Deal Amount

TECLens General Information


Developer of a non-invasive single treatment therapy designed to address the problem of Myopia. The company's therapy is assisted by Corneal Crosslinking Lens that is comfortable and may be worn with the eye open or closed and has a real-time ultrasound sensing for accurate prescription tuning, enabling eye specialists to assure Myopia treatment in a faster, secure and cost effective manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Medical Supplies
Primary Office
  • 9 Riverbend Drive South
  • Stamford, CT 06907
  • United States
+1 (631) 000-0000

TECLens Timeline

Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TECLens Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 06-Feb-2019 $200K 00.000 Completed Startup
2. Angel (individual) 02-Jun-2017 00.000 00.000 Completed Startup
1. Angel (individual) 01-Jan-2014 Completed Startup
To view TECLens’s complete valuation and funding history, request access »

TECLens Executive Team (4)

Name Title Board Seat Contact Info
David Acker Co-Founder & Chief Executive Officer
Patrick Lopath Co-Founder & Chief Operating Officer
Frances Chen Executive Vice President, Business Development
Roy Chuck Ph.D Co-Founder & Chairman of Medical Advisory Board
To view TECLens’s complete executive team members history, request access »

TECLens Board Members (1)

Name Representing Role Since
Roy Chuck Ph.D TECLens Co-Founder & Chairman of Medical Advisory Board 000 0000
To view TECLens’s complete board members history, request access »